Learning Objectives:

1.  Provide an update on current findings from the individual DodoNa cohorts.

2.  Discuss findings from the Parkinson's disease, migraine and neuromuscular cohorts and their clinical significance.

3.  Discuss the importance of the completeness of clinical data to reliably predict clinically actionable outcomes.

Session date: 
02/08/2022 - 8:00am to 9:00am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Aikaterini Markopoulou, MD,PhD